John I. Bell

24.1k total citations · 6 hit papers
107 papers, 16.0k citations indexed

About

John I. Bell is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, John I. Bell has authored 107 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Immunology, 16 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Genetics. Recurrent topics in John I. Bell's work include T-cell and B-cell Immunology (51 papers), Immune Cell Function and Interaction (41 papers) and Immunotherapy and Immune Responses (23 papers). John I. Bell is often cited by papers focused on T-cell and B-cell Immunology (51 papers), Immune Cell Function and Interaction (41 papers) and Immunotherapy and Immune Responses (23 papers). John I. Bell collaborates with scholars based in United Kingdom, United States and India. John I. Bell's co-authors include Paul Moss, Andrew J. McMichael, Hugh O. McDevitt, John A. Todd, Lon R. Cardon, Philip Goulder, Dan H. Barouch, Michael G. McHeyzer‐Williams, Mark M. Davis and John D. Altman and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John I. Bell

106 papers receiving 15.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phenotypic Analysis of Antigen-Specific T Lymphocytes

1996 3.0k citations Paul Moss, John I. Bell et al. profile →
HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

1987 1.6k citations John I. Bell, Hugh O. McDevitt et al. profile →
Association study designs for complex diseases

2001 1.0k citations John I. Bell et al. profile →
A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity

2005 690 citations John I. Bell et al. profile →
A Molecular Basis for MHC Class II—Associated Autoimmunity

1988 606 citations John I. Bell, Lawrence Steinman et al. profile →
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

2021 330 citations Koen B. Pouwels, Emma Pritchard et al. Nature Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
John I. Bell	9.5k	2.9k	2.9k	2.0k	1.9k	107	16.0k
Michael C. Carroll	16.1k 1.7×	5.5k 1.9×	1.8k 0.6×	2.2k 1.1×	2.1k 1.1×	265	26.8k
John A. Hansen	13.2k 1.4×	2.3k 0.8×	2.1k 0.7×	2.3k 1.1×	3.7k 1.9×	386	24.6k
Ronald E. Gress	12.5k 1.3×	3.3k 1.1×	1.8k 0.6×	2.6k 1.3×	6.5k 3.4×	259	20.5k
Takehiko Sasazuki	8.2k 0.9×	5.8k 2.0×	2.5k 0.9×	1.4k 0.7×	2.9k 1.5×	351	18.7k
George Janossy	9.2k 1.0×	3.3k 1.2×	1.2k 0.4×	2.8k 1.4×	1.9k 1.0×	298	18.9k
Kendall A. Smith	11.8k 1.2×	3.9k 1.4×	1.2k 0.4×	1.7k 0.8×	3.0k 1.6×	143	18.6k
Steven G. E. Marsh	14.6k 1.5×	2.5k 0.9×	1.8k 0.6×	1.2k 0.6×	1.2k 0.6×	634	19.1k
B. Paul Morgan	15.0k 1.6×	6.5k 2.3×	1.6k 0.6×	2.0k 1.0×	1.4k 0.7×	620	28.1k
Jacques J. M. van Dongen	9.4k 1.0×	7.6k 2.6×	2.4k 0.8×	1.7k 0.8×	4.9k 2.5×	504	28.0k
David Klatzmann	12.0k 1.3×	4.2k 1.4×	3.7k 1.3×	3.8k 1.8×	3.0k 1.5×	358	22.3k

Countries citing papers authored by John I. Bell

Since Specialization

Citations

This map shows the geographic impact of John I. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John I. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John I. Bell more than expected).

Fields of papers citing papers by John I. Bell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John I. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John I. Bell. The network helps show where John I. Bell may publish in the future.

Co-authorship network of co-authors of John I. Bell

This figure shows the co-authorship network connecting the top 25 collaborators of John I. Bell. A scholar is included among the top collaborators of John I. Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John I. Bell. John I. Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bell, John I., et al.. (2022). Redirecting Polyclonal T Cells against Cancer with Soluble T-Cell Receptors. Clinical Cancer Research. 29(4). 697–704. 18 indexed citations

Pymm, Phillip, Stefan Tenzer, Edmund G. Wee, et al.. (2022). Epitope length variants balance protective immune responses and viral escape in HIV-1 infection. Cell Reports. 38(9). 110449–110449. 3 indexed citations

Lee, Lennard Y. W., André Charlett, Charlotte Anderson, et al.. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission. Clinical Infectious Diseases. 74(3). 407–415. 79 indexed citations

Walker, A. Sarah, Emma Pritchard, Thomas House, et al.. (2021). Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time. eLife. 10. 65 indexed citations

Pritchard, Emma, Philippa C. Matthews, Nicole Stoesser, et al.. (2021). Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nature Medicine. 27(8). 1370–1378. 181 indexed citations

Chang, Chih‐Hao, Vattipally B. Sreenu, Ma Luo, et al.. (2015). HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression. Scientific Reports. 5(1). 11253–11253. 3 indexed citations

Bell, John I.. (2014). Stratified medicines: towards better treatment for disease. The Lancet. 383. S3–S5. 15 indexed citations

Cole, David K., Nicholas J. Pumphrey, Jonathan M. Boulter, et al.. (2007). Human TCR-Binding Affinity is Governed by MHC Class Restriction. The Journal of Immunology. 178(9). 5727–5734. 165 indexed citations

Chu, Fuliang, Zhiyong Lou, Yu Wai Chen, et al.. (2007). First Glimpse of the Peptide Presentation by Rhesus Macaque MHC Class I: Crystal Structures of Mamu-A*01 Complexed with Two Immunogenic SIV Epitopes and Insights into CTL Escape. The Journal of Immunology. 178(2). 944–952. 32 indexed citations

10.

Hourigan, Christopher S., et al.. (2006). The structure of the human allo‐ligand HLA‐B*3501 in complex with a cytochrome p450 peptide: Steric hindrance influences TCR allo‐recognition. European Journal of Immunology. 36(12). 3288–3293. 12 indexed citations

11.

Lang, Heather, Helle J. Jacobsen, Shinji Ikemizu, et al.. (2002). A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nature Immunology. 3(10). 940–943. 441 indexed citations

12.

Wyer, Jessica R., Benjamin E. Willcox, George F. Gao, et al.. (1999). T Cell Receptor and Coreceptor CD8αα Bind Peptide-MHC Independently and with Distinct Kinetics. Immunity. 10(2). 219–225. 171 indexed citations

13.

Willcox, Benjamin E., George F. Gao, Jessica R. Wyer, et al.. (1999). TCR Binding to Peptide-MHC Stabilizes a Flexible Recognition Interface. Immunity. 10(3). 357–365. 265 indexed citations

14.

Parkes, Miles, et al.. (1996). Liver. Gut. 39(Suppl 1). A18–A22. 2 indexed citations

15.

Bell, John I., et al.. (1995). T cell receptors. Oxford University Press eBooks. 5 indexed citations

16.

Lehner, Paul J., Eddie C. Y. Wang, Paul Moss, et al.. (1995). Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.. The Journal of Experimental Medicine. 181(1). 79–91. 232 indexed citations

17.

Moss, Paul, et al.. (1995). T‐Cell Receptor Usage of Major Histocompatibility Complex Class I Restricted Peptide‐Specific T‐Lymphocytes. Annals of the New York Academy of Sciences. 756(1). 12–18. 5 indexed citations

18.

Bowness, Paul, Paul Moss, Howard S. Tranter, John I. Bell, & Andrew J. McMichael. (1992). Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V beta 6.9 and V beta 22.. The Journal of Experimental Medicine. 176(3). 893–896. 39 indexed citations

19.

Lanchbury, Jerry S., Emma Jaeger, David M. Sansom, et al.. (1991). Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty's syndrome. Human Immunology. 32(1). 56–64. 59 indexed citations

20.

Bell, John I., Lawrence Steinman, Klaus V. Toyka, & Hugh O. McDevitt. (1987). HLA‐DQ Restriction Fragment Length Polymorphisms in Myasthenia Gravis^a. Annals of the New York Academy of Sciences. 505(1). 382–387. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact